This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knox, J J Articles by Gronostajski, R M Search for Related Content PubMed PubMed Citation Articles by Knox, J J Articles by Gronostajski, R M

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 June; 11(6): 2946-2951

In vivo stimulation of a chimeric promoter by binding sites for nuclear factor I.

Department of Medical Biophysics, University of Toronto, Ontario, Canada.

ABSTRACT

Nuclear factor I (NFI) is composed of a family of site-specific DNA-binding proteins which recognize a DNA-binding site with the consensus sequence TGGC/A(N)5GCCAA. Binding sites for NFI have previously been shown to stimulate mRNA synthesis in vitro when present upstream of the TATA box of the adenovirus major late promoter (AdMLP). We have examined the effect of NFI-binding sites on transcription in vivo in transiently transfected HeLa and COS cells. An NFI-binding site isolated from the human genome activated expression from the minimal AdMLP in vivo in both the absence and presence of the simian virus 40 enhancer. A point mutation that decreased NFI binding affinity for the site in vitro reduced expression to near the basal level of the AdMLP. Several NFI-binding sites which differed in their spacer and flanking sequences were tested for their ability to activate expression in vivo. The ability of these sites to activate expression correlated with the strength of NFI binding in vitro. An NFI-binding site stimulated expression equally well when placed from 33 to 65 bp upstream of the TATA box. However, expression dropped to basal levels when the site was located from 71 to 77 bp upstream of the TATA box. These studies indicate that an NFI-binding site in this chimeric promoter activates expression in vivo only if located within a critical distance of the TATA box.

This article has been cited by other articles:

• Chaudhry, A. Z., Vitullo, A. D., Gronostajski, R. M. (1999). Nuclear Factor I-mediated Repression of the Mouse Mammary Tumor Virus Promoter Is Abrogated by the Coactivators p300/CBP and SRC-1. J. Biol. Chem. 274: 7072-7081 [Abstract] [Full Text]  
• Chaudhry, A. Z., Vitullo, A. D., Gronostajski, R. M. (1998). Nuclear Factor I (NFI) Isoforms Differentially Activate Simple versus Complex NFI-responsive Promoters. J. Biol. Chem. 273: 18538-18546 [Abstract] [Full Text]  
• Prado, F., Koop, R., Beato, M. (2002). Accurate Chromatin Organization of the Mouse Mammary Tumor Virus Promoter Determines the Nature of the Synergism between Transcription Factors. J. Biol. Chem. 277: 4911-4917 [Abstract] [Full Text]